Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pocard

Showing results (121-130 of 277) with videos related to

Pageof 28
Sort By:
Pleura and Peritoneum|March 27, 2019
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and designFrédéric Dumont, Hélène Senellart, Francois Pein, et al.
Journal of Surgical Oncology|March 24, 2005
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastasesDominique Elias, Olivier Baton, Lucas Sideris, et al.
Annals of Surgical Oncology|December 2, 2017
Prediction of Resectability in Pseudomyxoma Peritonei with a New CT ScoreMorgane Bouquot, Anthony Dohan, Etienne Gayat, et al.
Gastroenterologie Clinique Et Biologique|November 1, 2006
Peritoneal carcinomatosis of colorectal originDominique Elias, Bruno Raynard, Ferechte Farkhondeh, et al.
BMC Cancer|June 20, 2020
Multi-nanolayer drug delivery using radiofrequency plasma technologyIman Al Dybiat, Alibi Baitukha, Cynthia Pimpie, et al.
Indian Journal of Surgical Oncology|June 26, 2023
Strategy for Oligometastatic Recurrence of Cardia Adenocarcinoma: Liver Radiofrequency Ablation Associated with PIPAC Inducing Response Permitting Cytoreductive Surgery and HIPECPierre Platevoet, Solene Doat, Jean-Baptiste Bachet, et al.
Annals of Surgery|April 17, 2010
A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendixDominique Elias, Olivier Glehen, Marc Pocard, et al.
Annals of Surgical Oncology|May 10, 2015
Insertion of a Stent in Obstructive Colon Cancer Can Induce a Metastatic Process in an Experimental Murine ModelBrice Malgras, Laura Brullé, Réa Lo Dico, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2019
Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model studyAbdelkader Taibi, Rea Lo Dico, Rachid Kaci, et al.
Annals of Surgical Oncology|December 17, 2013
Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal originClarisse Eveno, Guillaume Passot, Diane Goéré, et al.
Pageof 28

Showing results (121-130 of 277) with videos related to

Sort By:
Pageof 28
Pleura and Peritoneum|March 27, 2019
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and designFrédéric Dumont, Hélène Senellart, Francois Pein, et al.
Journal of Surgical Oncology|March 24, 2005
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastasesDominique Elias, Olivier Baton, Lucas Sideris, et al.
Annals of Surgical Oncology|December 2, 2017
Prediction of Resectability in Pseudomyxoma Peritonei with a New CT ScoreMorgane Bouquot, Anthony Dohan, Etienne Gayat, et al.
Gastroenterologie Clinique Et Biologique|November 1, 2006
Peritoneal carcinomatosis of colorectal originDominique Elias, Bruno Raynard, Ferechte Farkhondeh, et al.
BMC Cancer|June 20, 2020
Multi-nanolayer drug delivery using radiofrequency plasma technologyIman Al Dybiat, Alibi Baitukha, Cynthia Pimpie, et al.
Indian Journal of Surgical Oncology|June 26, 2023
Strategy for Oligometastatic Recurrence of Cardia Adenocarcinoma: Liver Radiofrequency Ablation Associated with PIPAC Inducing Response Permitting Cytoreductive Surgery and HIPECPierre Platevoet, Solene Doat, Jean-Baptiste Bachet, et al.
Annals of Surgery|April 17, 2010
A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendixDominique Elias, Olivier Glehen, Marc Pocard, et al.
Annals of Surgical Oncology|May 10, 2015
Insertion of a Stent in Obstructive Colon Cancer Can Induce a Metastatic Process in an Experimental Murine ModelBrice Malgras, Laura Brullé, Réa Lo Dico, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2019
Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model studyAbdelkader Taibi, Rea Lo Dico, Rachid Kaci, et al.
Annals of Surgical Oncology|December 17, 2013
Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal originClarisse Eveno, Guillaume Passot, Diane Goéré, et al.
Pageof 28